Acadia Healthcare Company, Inc. (Nasdaq: ACHC) acquired CRC Health Group, Inc. (CRC), a leading provider of treatment services related to substance abuse and other addiction and behavioral disorder, for $1.3 billion. At the time of closing, CRC operated 35 inpatient facilities with over 2,400 beds and 81 comprehensive treatment centers located in 30 states, and treated approximately 44,000 patients per day. The CRC acquisition was transformational for Acadia and represented the company's entry into the substance abuse market.
Waller assisted Acadia in all aspects of the transaction, including challenging real estate issues, Hart-Scott-Rodino compliance, and regulatory approvals. In addition, both CRC and Acadia had significant private equity ownership stakes, further complicating the dynamics. Extensive negotiations among the significant stockholders on matters of registration rights and other stockholder matters were required. Moreover, a portion of the consideration paid was in the form of Acadia stock requiring extensive securities law analysis and structuring. In addition to its role on the acquisition transaction, Waller acted as lead counsel to Acadia in financing the acquisition.
Acadia is the leading publicly traded pure-play provider of behavioral healthcare services, with operations in the United States and the United Kingdom.
Advised HCA in its $450 million asset purchase of Memorial University Medical Center in Savannah, Ga.
Assisted the parking company in successfully avoiding eviction and the parties ultimately reached a mutually agreeable resolution.
Successfully obtained a dismissal of an antitrust claim against RegionalCare Hospital Partners alleging monopolization of the northwest Alabama market.